Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55

被引:55
作者
Abbott, Rachel J. M.
Spendlove, Ian
Roversi, Pietro
Fitzgibbon, Hannah
Knott, Vroni
Teriete, Peter
McDonnell, James M.
Handford, Penny A.
Lea, Susan M.
机构
[1] Univ Nottingham, City Hosp, Sch Mol Med Sci, Acad Clin Oncol, Nottingham NG5 1PB, England
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
[3] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
基金
英国医学研究理事会;
关键词
D O I
10.1074/jbc.M702588200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD97, the archetypal member of the EGF-TM7 protein family, is constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells following activation. The key isoform of CD97 expressed on leukocytes binds the complement regulatory protein CD55 (also termed decay-accelerating factor). CD97 has been shown recently to mediate co-stimulation of T cells via CD55. Here, we demonstrate that blocking the interaction between CD55 on monocytes and CD97 on T cells leads to inhibition of proliferation and interferon-gamma secretion. This implies that bidirectional interactions between CD97 and CD55 are involved in T cell regulation. Structural studies presented here reveal the molecular basis for this activity. We have solved the structure of EMR2, a very close homolog of CD97, using x-ray crystallography. NMR-based chemical shift mapping of the EMR2-CD55 interaction has allowed us to generate a model for the CD97-CD55 complex. The structure of the complex reveals that the T cell and complement regulatory activities of CD55 occur on opposite faces of the molecule. This suggests that CD55 might simultaneously regulate both the innate and adaptive immune responses, and we have shown that CD55 can still regulate complement when bound to CD97.
引用
收藏
页码:22023 / 22032
页数:10
相关论文
共 44 条
[1]   Crystallization and preliminary X-ray diffraction analysis of three EGF domains of EMR2, a 7TM immune-system molecule [J].
Abbott, RJM ;
Knott, V ;
Roversi, P ;
Neudeck, S ;
Lukacik, P ;
Handford, PA ;
Lea, SM .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :936-938
[2]   Methods used in the structure determination of bovine mitochondrial F-1 ATPase [J].
Abrahams, JP ;
Leslie, AGW .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 :30-42
[3]  
Aust G, 2002, AM J CLIN PATHOL, V118, P699
[4]   Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT [J].
Blanc, E ;
Roversi, P ;
Vonrhein, C ;
Flensburg, C ;
Lea, SM ;
Bricogne, G .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2210-2221
[5]   Costimulation via CD55 on human CD4+ T cells mediated by CD97 [J].
Capasso, Melania ;
Durrant, Lindy G. ;
Stacey, Martin ;
Gordon, Siamon ;
Ramage, Judith ;
Spendlove, Ian .
JOURNAL OF IMMUNOLOGY, 2006, 177 (02) :1070-1077
[6]   CD312, the human adhesion-GPCR EMR2, is differentially expressed during differentiation, maturation, and activation of myeloid cells [J].
Chang, Gin-Wen ;
Davies, John Q. ;
Stacey, Martin ;
Yona, Simon ;
Bowdish, Dawn M. E. ;
Hamann, Jorg ;
Chen, Tse-Ching ;
Lin, Chun-Yen ;
Gordon, Siamon ;
Lin, Hsi-Hsien .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 353 (01) :133-138
[7]   Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods [J].
delaFortelle, E ;
Bricogne, G .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :472-494
[8]   HADDOCK: A protein-protein docking approach based on biochemical or biophysical information [J].
Dominguez, C ;
Boelens, R ;
Bonvin, AMJJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (07) :1731-1737
[9]   Expression characteristics of the human CD97 antigen [J].
Eichler, W ;
Hamann, J ;
Aust, G .
TISSUE ANTIGENS, 1997, 50 (05) :429-438
[10]   Structure and function of the epidermal growth factor domain of P-selectin [J].
Freedman, SJ ;
Sanford, DG ;
Bachovchin, WW ;
Furie, BC ;
Baleja, JD ;
Furie, B .
BIOCHEMISTRY, 1996, 35 (43) :13733-13744